Právní předpis byl sestaven k datu 25.10.2026.
Zobrazené znění právního předpisu je účinné od 22.02.2023.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2023
41/2023 Sb.
41
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 10. xxxxx 2023
o xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2023
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x ochraně xxxxxxxxx xxxxxx x x xxxxx některých xxxxxxxxxxxxx xxxxxx, xx znění xxxxxxxxxx předpisů, xxxxxxx xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2023:
1. Antigenní xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus influenzae xxx b (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 ne xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (IU)
Tetani xxxxxxxxxx1 xx xxxx xxx 40 mezinárodních jednotek (XX)
Xxxxxxxx Bordetelly xxxxxxxxx:
Xxxxxxxxx xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)1 25 xxxxxxxxxx Xxxxxxxxxxx (XXX)1 8 xxxxxxxxxx
Xxxxxxxxx tegiminis hepatitidis X (HBs)2,3 10 xxxxxxxxxx
Xxxxx poliomyelitidis xxxxxxxxxxx (XXX)
xxxxx 1 (xxxx Xxxxxxx)4 40 D xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Saukett)4 32 D xxxxxxxx xxxxxxxx
Xxxxxxxxxxx influenzae typus x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phosphas) 10 mikrogramů
conj. cum xxxxxx. xxxxxxxx xxxx xxxxx xxxxxxx xxxxxxxxx 25 xxxxxxxxxx
1 adsorbováno xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 xxxxxxxxx Al3+
2 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx Xxxxxxxxxxxxx xxxxxxxxxx)
3 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx (XxXX4) 0,32 xxxxxxxxx Al3+
4 pomnoženo xx XXXX buňkách
NEBO
1aa) xxxxxxxxxxx očkovací xxxxx xxxxx xxxxxxx, dávivému xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx hepatitidě B, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx typ x (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xx xxxx xxx 20 mezinárodních xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxxxx Xxxxxxxxxx pertussis
Pertussis anatoxinum 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Mahoney) 40 X xxxxxxxx xxxxxxxx4
xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx4
Xxxxxxxxx tegiminis hepatitidis X5 10 xxxxxxxxxx
Xxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx xxxxxxxxxx X 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx cum tetani xxxxxxxxxx 22-36 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (0,6 xx Al3+)
2 jako xxxxxx xxx xxxxxxxxxxxxx (x = 0,95)
3 xxxxxxxxx xx XXXX xxxxxxx
4 nebo ekvivalentní xxxxxxxx antigenu xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx
5 xxxxxxxx xxxxxxxxxxxxx DNA xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxx
XXXX
1xx) Xxxxxxx xxxxx xxxxxxx, xxxxxx, xxxxxxxx kašli (xxxxxxxxxx komponenta), hepatitidě X (xXXX), xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx) x konjugovaná xxxxxxx xxxxx Xxxxxxxxxxx xxxx x (xxxxxxxxxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 20 XX
Xxxxxx xxxxxxxxxx1 ne méně xxx 40 XX
Xxxxxxxx Xxxxxxxxxxx pertusis1
Pertussis anatoxinum (XX) 20 mikrogramů
Haemagglutinium xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (XXX) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (FIM) 5 xxxxxxxxxx
Xxxxxxxxx tegiminis xxxxxxxxxxx B2,3 10 xxxxxxxxxx
Xxxxx poliomyelitidis (xxxxxxxxxxx)4
Xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx5
Xxxxx 2 (XXX-1) 8 X jednotek xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X jednotek xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx xxxxxxxxxx typus x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 xxxxxxxxxx xxxxxxxxxx xxx xxxxxxxxx meningococci typus x2 50 xxxxxxxxxx
1 xxxxxxxxxxx xx fosforečnan xxxxxxx (0,17 xx Xx3+)
2 adsorbováno na xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx (0,15 xx Xx3+)
3 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx
4 xxxxxxxxx xx Xxxx xxxxxxx
5 xxxx xxxxxxxxxxxx xxxxxxxx antigenu xxxxxxxxx xxxxxxx imunochemickou xxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (acelulární forma), xxxxxx (DTaP)
Jedna xxxxx (0,5 ml) xxxxxxxx xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx anatoxinum* (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx filamentosum* (FHA) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69 xX) 8 xxxxxxxxxx
* xxxxxxxxxxx xx xxxxxxxx xxxxxxx celkem: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx x dávivému xxxxx (xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxx xxxxxxxxxx - Minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx fosforečnan xxxxxxx - 1,5 xx (0,33 mg xxxxxxx)
* Jako xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx podle xxxxx popsaného v Xxxxxxxxx xxxxxxxx.
XXXX
1xx) Očkovací xxxxx proti záškrtu, xxxxxx x dávivému xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 xx méně xxx 2 mezinárodní xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 xx xxxx než 20 xxxxxxxxxxxxx jednotek (XX) (5 Lf)
Bordetellae pertussis xxxxxxxx:
Xxxxxxxxx anatoxinum1 8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1 8 mikrogramů
Pertussis membranae xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Al3+
1c) očkovací xxxxx proti nákazám xxxxxxxxx Xxxxxxxxxxx influenzae xxx b:
Jedna xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx:
Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) cum Xxxxxxxxx xxxxxxxx (přibližně 25 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx xxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxx xxxxxxxxxx - xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X v xxxxxx xxxxxxx:
Xxxxx xxxxx obsahuje:
Antigenum xxxxxxxxx xxxxxxxxxxx X - 10 xxxxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx B x dospělé xxxxxxx
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B - 20 mikrogramů
1g) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx1 (Schwarz) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
Parotitidis xxxxx attenuatum1 (RIT 4385) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Wistar RA 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 pomnoženo xx xxxxxxxx xxxxxxxxxxx buňkách (XXX-5)
3 50% infekční xxxxx tkáňové kultury
NEBO
1ga) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x xxxxxxxxx
Xx rozpuštění obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Enders’ Xxxxxxxxx) ne méně xxx 1x103 CCID50*
Virus xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx B) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 vivum xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 vyrobeno xx xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx lidských xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxx xxxxx x inaktivované xxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx).....40 xxxxxxxxxxx X jednotek*
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ..........8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx)........32 antigenních X xxxxxxxx*
* xxxx xxxxxxxx xxxxxxxxxxxxxx antigenů xxxxxxxxx xxxxxx xxxxxx imunochemické xxxxxx.
1xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxx xxxxxxxx:
1xxx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 11 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 31 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 41 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 4,4 µg
Streptococci pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 7X1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9V1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 141 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18C1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19A1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19F1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23F1 2,2 µx
1 Xxxxxxxxxx x nosným proteinem XXX197 x xxxxxxxxxx xx xxxxxxxxxxx hlinitý (0,125 mg xxxxxxx).
1xxx) xxxxxxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10X, 11A, 12X, 14, 15X, 17F, 18X, 19X, 19A, 20, 22X, 23X, 33X.
1x) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma):
Jedna xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 - xx xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 - xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (IU) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx anatoxinum1 - 8 mikrogramů
Pertussis xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx)2 - 40 X jednotek xxxxxxxx
xxxxx 2 (kmen XXX-1)2 - 8 X jednotek xxxxxxxx
xxxxx 3 (kmen Xxxxxxx)2 - 32 X xxxxxxxx xxxxxxxx
1 Adsorbováno xx xxxxxxxxxxx hydroxid xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Al3+ a xxxxxxxxxxx xxxxxxx (AlPO4) 0,2 xxxxxxxxx Al3+
2 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (inaktivovaná xxxxx):
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx anatoxinum xxxxxxxxx 2 XX* (2,5 Xx)
Xxxxxx anatoxinum xxxxxxxxx 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, typi 2 xx 3 5 xxxxxxxxxx
Xxxxx poliomyelitidis (xxxxxxxxxxx)**
xxxxx 1 40 X jednotek xxxxxxxx
xxxxx 2 8 D xxxxxxxx xxxxxxxx
xxxxx 3 32 X jednotek xxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx 1,5 xx (0,33 xx hliníku)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx spolehlivosti (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx v Evropském xxxxxxxx.
** Xxxxxxxxxxx xx Xxxx xxxxxxx.
1x) očkovací xxxxx proti xxxxxxxxxxx (XXX xxxxxxx)
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X pro xxxxx xxxxxxxx do xxxxxxxxxxxx programu:
Jedna dávka (0,5 ml) vakcíny xxxxxxxx:
Xxxxxxxxx tegiminis hepatitidis X1,2,3 - 20 xxxxxxxxxx
1 adjuvovaný xx XX04X xxxxxxxxxx: - 3-0-xxxxxx-4'-xxxxxxxxxxxx-xxxxx A (XXX)2 50 xxxxxxxxxx
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (xxxxxx 0,5 xxxxxxxxx Xx3+)
3 vyrobeno xx xxxxxxx xxxxxxxxxxxx buněk (Xxxxxxxxxxxxx xxxxxxxxxx) rekombinantní XXX xxxxxxxxxxx.
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxx očkování
2a) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X - 20 xxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx
2x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:
Jedna dávka xxxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
2x) očkovací látka xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám:
Jedna dávka xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
Parotitidis xxxxx xxxxxxxxxx1 (RIT 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
1 xxxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx na xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% infekční xxxxx xxxxxxx xxxxxxx
XXXX
2xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx obsahuje xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Enders’ Xxxxxxxxx) xx méně než 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxx Lynn™, xxxxxxx X) xx méně xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % infekční xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx embryí.
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 fibroblastech.
3. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X ve xxxxxxx xxx xxxxxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A ve xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx A xxxxxxxxxxx
3x) xxxxxxxx látka xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx attenuatum1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx503
Xxxxxxxxxxx virus xxxxxxxxxx1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) min. 103,0 infekční dávka xxx buněčnou kulturu503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx embryí
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
3xx) xxxxxxxx látka xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám
Po rozpuštění xxxxxxxx xxxxx dávka (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) ne xxxx xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (kmen Xxxxx Xxxx™, xxxxxxx B) xx méně xxx 12,5x103 CCID503
Virus rubeolae2 xxxxx xxxxxxxxxx (kmen Xxxxxx XX 27/3) xx xxxx než 1x1103 CCID503
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx lidských xxxxxxxxxxx plicních XX-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Xxxxx, XXx., XXX, XXXX, x. r.
Informace
Právní předpis č. 41/2023 Xx. xxxxx xxxxxxxxx xxxx 22.2.2023.
Xx xxx uzávěrky xxxxxx xxxxxxx xxxxx xxxxx xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační změna xxxxx uvedeného xxxxxxxx xxxxxxxx.